Shandong Sito Bio-technology Co., Ltd. (SHE:300583)
China flag China · Delayed Price · Currency is CNY
14.13
-0.80 (-5.36%)
Sep 2, 2026, 2:20 PM CST

SHE:300583 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
260.63295.07255.96238.49188.4161.5
Cash & Short-Term Investments
260.63295.07255.96238.49188.4161.5
Cash Growth
-4.08%15.28%7.33%26.59%16.66%-53.12%
Accounts Receivable
512.86485.37336.71383.2285.22301.81
Other Receivables
47.1213.0422.7311.5511.77
Receivables
516.87492.48349.75405.93296.77313.58
Inventory
458.28477.24644.88722.62608.26531.26
Prepaid Expenses
----2.13-
Other Current Assets
32.6919.7434.3330.7444.3873.97
Total Current Assets
1,2681,2851,2851,3981,1401,080
Property, Plant & Equipment
1,4091,3941,4611,5561,6061,643
Long-Term Investments
74.4174.0468.6865.1263.259.18
Other Intangible Assets
179.97182.86189.15200.58172.9178.85
Long-Term Deferred Tax Assets
13.7713.1116.211.278.951.93
Long-Term Deferred Charges
0.40.610.791.3-1.21
Other Long-Term Assets
8.786.85.428.275.114.99
Total Assets
2,9552,9563,0263,2402,9962,970

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
369.92292.26307.43246.82402.69460.8
Accrued Expenses
10.0719.7813.132.1127.1324.33
Short-Term Debt
533.21609.59642.56634.11590.14477.48
Current Portion of Long-Term Debt
54.0640.6419.746.2233.8945.17
Current Portion of Leases
-18.0519.452.762.61.99
Current Income Taxes Payable
13.054.871.44.085.2510.6
Current Unearned Revenue
5.44.714.795.5810.4718.06
Other Current Liabilities
19.115.9715.2515.0712.2816.55
Total Current Liabilities
1,0051,0061,024986.761,0841,055
Long-Term Debt
137.48133.7774.28108.34122.7161.97
Long-Term Leases
-1.1221.6954.381.011.89
Long-Term Unearned Revenue
16.6418.1921.3324.5515.1617.76
Long-Term Deferred Tax Liabilities
--0.670.771.471.09
Total Liabilities
1,1591,1591,1421,1751,2251,238

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
189.7189.7189.7189.7106.92107.25
Additional Paid-In Capital
1,2771,2771,2771,2771,1081,117
Retained Earnings
324.8295.52372.46546.6502.77462.32
Treasury Stock
-30-----7.99
Comprehensive Income & Other
----1.12.634.34
Total Common Equity
1,7611,7621,8392,0121,7201,683
Minority Interest
34.4434.5145.0453.2950.7449.28
Shareholders' Equity
1,7961,7971,8842,0651,7711,732
Total Liabilities & Equity
2,9552,9563,0263,2402,9962,970

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
724.75803.17777.68845.81750.35688.5
Net Cash (Debt)
-464.12-508.1-521.72-607.32-561.95-527
Net Cash Growth
------
Net Cash Per Share
-2.47-2.71-2.76-3.33-3.21-3.09
Filing Date Shares Outstanding
197.01189.7189.7189.7171.08171.6
Total Common Shares Outstanding
197.01189.7189.7189.7171.08171.6
Working Capital
263.67278.66261.24411.0355.4825.31
Book Value Per Share
8.949.299.6910.6110.059.81
Tangible Book Value
1,5811,5791,6501,8121,5471,504
Tangible Book Value Per Share
8.038.338.709.559.048.76
Buildings
-663.65551.52593.55582.43535.73
Machinery
-1,5351,5031,51169.211,284
Construction In Progress
-231.26281.7279.29292.42356.9